Borkent J, Ioannou M, Neijzen D, et al. Probiotic Formulation for Patients With Bipolar or Schizophrenia Spectrum Disorder: A Double-Blind, Randomized Placebo-Controlled Trial. Schizophr Bull. 6:sbae188, 2024. doi: 10.1093/schbul/sbae188. Epub ahead of print. PMID: 39504580.
Bu F, Bone JK, Fancourt D. Will things feel better in the morning? A time-of-day analysis of mental health and wellbeing from nearly 1 million observations. BMJ Mental Health 2025;28:e301418.
Cunningham C, Macdonald O, Schaffer A, et al. Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPP. BMJ Mental Health 2025;28:e301378.
Degasperi G, Meneo D, Curati S, et al. Sleep quality in eating disorders: A Systematic Review and Meta-Analysis. Sleep Medicine Reviews, 101969.
Egan SJ, Greene D, Callaghan T, et al. Worry and rumination as a transdiagnostic target in young people: a co-produced systematic review and meta-analysis. Cognitive Behaviour Therapy 2025, 54(1), 17-40.
Ermis C, Taipale H, Tanskanen A, et al. Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort. The Lancet Psychiatry 2025.
Karemyr M, Bellander M, Pontén M, et al. Preventing suicide with Safe Alternatives for Teens and Youths (SAFETY): a randomised feasibility trial. BMJ Mental Health 2025;28:e301575.
Kip A, Weigand L, Valencia S, et al. Prevention of mental disorders after exposure to natural hazards: a meta-analysis. BMJ Mental Health 2025;28:e301357.
Krakau L, Ernst M, Hautzinger M, et al. Childhood trauma and differential response to long-term psychoanalytic versus cognitive–behavioural therapy for chronic depression in adults. The British Journal of Psychiatry 2024, 1-8.
Kypriotakis G, Cinciripini P, Green C, et al. Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons with Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomised, Placebo-Controlled Trial. The American Journal of Psychiatry 2024.
Larsen AJ, Teobaldi G, Espinoza RI, et al. Effectiveness of pharmacological and non-pharmacological interventions for treatment-resistant depression in older patients: a systematic review and meta-analysis. BMJ Mental Health 2025;28:e301324.
Li Y, Chen C, Chen Q, et al. Effects of selective serotonin reuptake inhibitors (SSRIs) on suicide: A network meta-analysis of double-blind randomized trials. Psychiatry Research 2024, Jun:336:115917. doi: 10.1016/j.psychres.2024.115917
Nguyen PV, Dang-Vu TT, Forest G, et al. Mirtazapine for chronic insomnia in older adults: a randomised double-blind placebo-controlled trial-the MIRAGE study. Age Ageing. 2025 Mar 3;54(3):afaf050. doi: 10.1093/ageing/afaf050. PMID: 40135470.
Noetel M, Sanders T, Gallardo-Gómez D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials – PubMed. British Medical Journal 2024, 384 q1024.
O’Donnell AT, Foran A-M. The link between anticipated and internalized stigma and depression: A systematic review. Social Science & Medicine 2024, 349, 116869–116869.
Rowe AL, Perich T, Meade T. Bipolar disorder and cumulative trauma: A systematic review of prevalence and illness outcomes. Journal of Clinical Psychology 2024, 80, 692–713. https://doi.org/10.1002/jclp.23650
Schaug JP, Møller L, Reinholt N, et al. Psychotherapies for adults with complex presentations of PTSD: a clinical guideline and five systematic reviews with meta-analyses. BMJ Mental Health 2025;28:e301158.
